NextCell Pharma AB
STO:NXTCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NextCell Pharma AB
STO:NXTCL
|
SE |
|
A
|
Active Biotech AB publ
STO:ACTI
|
SE |
|
G
|
Great Republic Mining Corp
CNSX:GRM
|
CA |
|
Parkland Corp
TSX:PKI
|
CA |
|
X
|
Xueda Xiamen Education Technology Group Co Ltd
SZSE:000526
|
CN |
NextCell Pharma AB
NextCell Pharma AB engages in the development of stem cell products. The company is headquartered in Huddinge, Stockholm. The company went IPO on 2017-07-13. The firm is focusing on research and development of stem cell therapies and is also running a tissue establishment and biobank, classified as healthcare provider. NextCell's business concept is to develop and commercialize mesenchymal stem cell products based on the Company's proprietary selection algorithm, primarily for the treatment of autoimmune diabetes, as well as other types of autoimmune diseases.
NextCell Pharma AB engages in the development of stem cell products. The company is headquartered in Huddinge, Stockholm. The company went IPO on 2017-07-13. The firm is focusing on research and development of stem cell therapies and is also running a tissue establishment and biobank, classified as healthcare provider. NextCell's business concept is to develop and commercialize mesenchymal stem cell products based on the Company's proprietary selection algorithm, primarily for the treatment of autoimmune diabetes, as well as other types of autoimmune diseases.
